Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Quarterly results
PTC THERAPEUTICS, INC. (PTCT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
08/04/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
10/28/2021 8-K Quarterly results
07/29/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
10/29/2020 8-K Quarterly results
08/05/2020 8-K Quarterly results
04/30/2020 8-K Quarterly results
Docs: "PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update - Risdiplam demonstrated clinically meaningful and statistically significant results across broadest population of spinal muscular atrophy patients studied to date; PDUFA date August 24, 2020 - - PTC provides an update on clinical and regulatory programs - - First quarter 2020 total revenues were $68.3 million, 27% year over year growth -"
03/02/2020 8-K Quarterly results
10/29/2019 8-K Quarterly results
Docs: "PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update Tegsedi® approved in Brazil & PTC is prepared for launch PTC completed financing with net proceeds of approximately $376 million"
08/06/2019 8-K Quarterly results
05/02/2019 8-K Quarterly results
Docs: "PTC Therapeutics Reports First Quarter 2019 Financial Results and Provides a Corporate Update Translarna™ Approved by Brazilian Health Regulatory Authority Waylivra™ Receives Positive CHMP Opinion"
02/28/2019 8-K Quarterly results
11/05/2018 8-K Quarterly results
Docs: "PTC Therapeutics Reports Third Quarter 2018 Financial Results and Provides a Corporate Update -Completed acquisition of Agilis Biotherapeutics gene therapy platform- -In-licensed two rare disease therapies from Akcea Therapeutics-"
08/07/2018 8-K Quarterly results
Docs: "PTC Therapeutics Reports Second Quarter 2018 Financial Results and Provides a Corporate Update Entered into agreement to acquire Agilis Biotherapeutics In-licensed LATAM commercial rights to Tegsedi™ and Waylivra™ EC approval of Translarna™ label expansion to children as young as 2 years of age Compelling data from FIREFISH study"
05/09/2018 8-K Quarterly results
Docs: "PTC Therapeutics Reports First Quarter 2018 Financial Results and Provides a Corporate Update"
03/06/2018 8-K Quarterly results
Docs: "PTC Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update - 2017 total revenues of $194M, a 135% increase vs. 2016 - - Full year 2018 net product revenue guidance of $260M to $295M – - Conference call at 4:30 p.m. ET -"
11/02/2017 8-K Quarterly results
Docs: "PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update - Total third quarter revenue of $41.9M representing 82% growth over 3Q2016 - - Increasing 2017 revenue guidance to $160-$185M -"
08/08/2017 8-K Quarterly results
Docs: "Consulting Services Agreement between the Registrant and Mark A. Rothera",
"PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update - Translarna™ second quarter sales of $45.8 M representing 197% growth over 2Q2016 - - Over 1,200 patients on EMFLAZA™ 12 weeks into launch - - ~400% dose-dependent increase in full length SMN2 mRNA shown in SUNFISH trial interim analysis - - 2017 revenue guidance increased to $155-180 M -"
05/08/2017 8-K Form 8-K - Current report
03/16/2017 8-K Form 8-K - Current report
11/02/2016 8-K Form 8-K - Current report
05/05/2016 8-K Form 8-K - Current report
02/29/2016 8-K Form 8-K - Current report
11/09/2015 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND REVIEWS KEY FINDINGS FROM ACT DMD"
07/30/2015 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
05/04/2015 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
02/27/2015 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS FOURTH QUARTER AND 2014 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
11/06/2014 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
08/07/2014 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
05/06/2014 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
03/06/2014 8-K Quarterly results
Docs: "PTC THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2013 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy